Arch Biopartners (TSXV:ARCH) Price-to-Operating-Cash-Flow : (As of May. 14, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners Price-to-Operating-Cash-Flow?

As of today (2024-05-14), Arch Biopartners's share price is C$1.71. Arch Biopartners's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.03. Hence, Arch Biopartners's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Arch Biopartners's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Arch Biopartners's highest Price-to-Operating-Cash-Flow Ratio was 510.00. The lowest was 0.00. And the median was 0.00.

TSXV:ARCH's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.57
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Arch Biopartners's Cash Flow from Operations per share for the three months ended in Dec. 2023 was C$-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.03.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Arch Biopartners was -680.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 50.00% per year.

During the past 13 years, Arch Biopartners's highest 3-Year average Operating Cash Flow per Share Growth Rate was 68.40% per year. The lowest was -61.60% per year. And the median was 8.05% per year.

Arch Biopartners Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Arch Biopartners's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Price-to-Operating-Cash-Flow Chart

Arch Biopartners Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

376.25

Arch Biopartners Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															562.00	-	284.29	-	-

Competitive Comparison of Arch Biopartners's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Arch Biopartners's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Biopartners's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's Price-to-Operating-Cash-Flow falls into.

Arch Biopartners Price-to-Operating-Cash-Flow Calculation

Arch Biopartners's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.71	/	-0.029
	=

Arch Biopartners's Share Price of today is C$1.71.
Arch Biopartners's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.03.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Arch Biopartners Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Biopartners (TSXV:ARCH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

545 King Street West, Toronto, ON, CAN, M5V 1M1

Website

https://www.archbiopartners.com

Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.